HIPPO HOLDINGS INC (HIPO) Fundamental Analysis & Valuation

NYSE:HIPO • US4335392027

Current stock price

27.73 USD
+1.4 (+5.32%)
At close:
27.73 USD
0 (0%)
After Hours:

This HIPO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. HIPO Profitability Analysis

1.1 Basic Checks

  • HIPO had positive earnings in the past year.
  • In the past year HIPO has reported a negative cash flow from operations.
  • HIPO had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: HIPO reported negative operating cash flow in multiple years.
HIPO Yearly Net Income VS EBIT VS OCF VS FCFHIPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M

1.2 Ratios

  • The Return On Assets of HIPO (5.12%) is better than 77.55% of its industry peers.
  • HIPO has a Return On Equity of 22.75%. This is amongst the best in the industry. HIPO outperforms 87.07% of its industry peers.
Industry RankSector Rank
ROA 5.12%
ROE 22.75%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HIPO Yearly ROA, ROE, ROICHIPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • HIPO has a Profit Margin of 21.31%. This is amongst the best in the industry. HIPO outperforms 85.03% of its industry peers.
  • HIPO does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 21.31%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HIPO Yearly Profit, Operating, Gross MarginsHIPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. HIPO Health Analysis

2.1 Basic Checks

  • HIPO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for HIPO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HIPO Yearly Shares OutstandingHIPO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HIPO Yearly Total Debt VS Total AssetsHIPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • HIPO has an Altman-Z score of -0.39. This is a bad value and indicates that HIPO is not financially healthy and even has some risk of bankruptcy.
  • HIPO's Altman-Z score of -0.39 is fine compared to the rest of the industry. HIPO outperforms 65.99% of its industry peers.
  • HIPO has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
  • HIPO's Debt to Equity ratio of 0.11 is fine compared to the rest of the industry. HIPO outperforms 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -0.39
ROIC/WACCN/A
WACC9.03%
HIPO Yearly LT Debt VS Equity VS FCFHIPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • HIPO has a Current Ratio of 3.79. This indicates that HIPO is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of HIPO (3.79) is better than 93.88% of its industry peers.
  • A Quick Ratio of 3.79 indicates that HIPO has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.79, HIPO belongs to the top of the industry, outperforming 93.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.79
Quick Ratio 3.79
HIPO Yearly Current Assets VS Current LiabilitesHIPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. HIPO Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 287.25% over the past year.
  • The Revenue has grown by 25.93% in the past year. This is a very strong growth!
  • The Revenue has been growing by 55.46% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)287.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%134.03%
Revenue 1Y (TTM)25.93%
Revenue growth 3Y57.6%
Revenue growth 5Y55.46%
Sales Q2Q%10.15%

3.2 Future

  • HIPO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.38% yearly.
  • Based on estimates for the next years, HIPO will show a very strong growth in Revenue. The Revenue will grow by 22.06% on average per year.
EPS Next Y-84.03%
EPS Next 2Y-33.6%
EPS Next 3Y30.38%
EPS Next 5YN/A
Revenue Next Year25.33%
Revenue Next 2Y23.82%
Revenue Next 3Y22.06%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HIPO Yearly Revenue VS EstimatesHIPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
HIPO Yearly EPS VS EstimatesHIPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 -5 -10

More info and screens

Find the best growth stocksShow best growing peers

3

4. HIPO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 5.90, which indicates a rather cheap valuation of HIPO.
  • 78.91% of the companies in the same industry are more expensive than HIPO, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of HIPO to the average of the S&P500 Index (26.64), we can say HIPO is valued rather cheaply.
  • The Price/Forward Earnings ratio is 29.39, which means the current valuation is very expensive for HIPO.
  • Based on the Price/Forward Earnings ratio, HIPO is valued a bit more expensive than the industry average as 79.59% of the companies are valued more cheaply.
  • When comparing the Price/Forward Earnings ratio of HIPO to the average of the S&P500 Index (21.36), we can say HIPO is valued slightly more expensively.
Industry RankSector Rank
PE 5.9
Fwd PE 29.39
HIPO Price Earnings VS Forward Price EarningsHIPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HIPO Per share dataHIPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as HIPO's earnings are expected to grow with 30.38% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-33.6%
EPS Next 3Y30.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HIPO Dividend Analysis

5.1 Amount

  • No dividends for HIPO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HIPO Fundamentals: All Metrics, Ratios and Statistics

HIPPO HOLDINGS INC

NYSE:HIPO (5/1/2026, 8:04:00 PM)

After market: 27.73 0 (0%)

27.73

+1.4 (+5.32%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Industry Strength2.48
Industry Growth85.71
Earnings (Last)04-30
Earnings (Next)08-04
Inst Owners48.24%
Inst Owner Change-0.1%
Ins Owners10.97%
Ins Owner Change1.95%
Market Cap720.15M
Revenue(TTM)468.60M
Net Income(TTM)95.90M
Analysts80
Price Target38.51 (38.87%)
Short Float %2.49%
Short Ratio4.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)98.4%
Min EPS beat(2)89.54%
Max EPS beat(2)107.26%
EPS beat(4)3
Avg EPS beat(4)215.38%
Min EPS beat(4)-18.4%
Max EPS beat(4)683.12%
EPS beat(8)6
Avg EPS beat(8)113.05%
EPS beat(12)7
Avg EPS beat(12)69.89%
EPS beat(16)7
Avg EPS beat(16)40.05%
Revenue beat(2)1
Avg Revenue beat(2)0.27%
Min Revenue beat(2)-0.53%
Max Revenue beat(2)1.08%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-0.53%
Max Revenue beat(4)2.13%
Revenue beat(8)5
Avg Revenue beat(8)3.95%
Revenue beat(12)8
Avg Revenue beat(12)4.79%
Revenue beat(16)9
Avg Revenue beat(16)3.48%
PT rev (1m)-5.04%
PT rev (3m)-5.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)246.54%
EPS NY rev (3m)1575%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.76%
Revenue NY rev (3m)6.31%
Valuation
Industry RankSector Rank
PE 5.9
Fwd PE 29.39
P/S 1.6
P/FCF N/A
P/OCF N/A
P/B 1.71
P/tB 1.98
EV/EBITDA N/A
EPS(TTM)4.7
EY16.95%
EPS(NY)0.94
Fwd EY3.4%
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS17.33
BVpS16.23
TBVpS14.02
PEG (NY)N/A
PEG (5Y)N/A
Graham Number41.4289 (49.4%)
Profitability
Industry RankSector Rank
ROA 5.12%
ROE 22.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 21.31%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.9%
Cap/Sales 2.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.79
Quick Ratio 3.79
Altman-Z -0.39
F-Score6
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)117.59%
Cap/Depr(5y)128.11%
Cap/Sales(3y)9.44%
Cap/Sales(5y)12.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)287.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%134.03%
EPS Next Y-84.03%
EPS Next 2Y-33.6%
EPS Next 3Y30.38%
EPS Next 5YN/A
Revenue 1Y (TTM)25.93%
Revenue growth 3Y57.6%
Revenue growth 5Y55.46%
Sales Q2Q%10.15%
Revenue Next Year25.33%
Revenue Next 2Y23.82%
Revenue Next 3Y22.06%
Revenue Next 5YN/A
EBIT growth 1Y72.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year157.68%
EBIT Next 3Y64.73%
EBIT Next 5YN/A
FCF growth 1Y-19.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-107.41%
OCF growth 3YN/A
OCF growth 5YN/A

HIPPO HOLDINGS INC / HIPO Fundamental Analysis FAQ

What is the fundamental rating for HIPO stock?

ChartMill assigns a fundamental rating of 4 / 10 to HIPO.


What is the valuation status for HIPO stock?

ChartMill assigns a valuation rating of 3 / 10 to HIPPO HOLDINGS INC (HIPO). This can be considered as Overvalued.


How profitable is HIPPO HOLDINGS INC (HIPO) stock?

HIPPO HOLDINGS INC (HIPO) has a profitability rating of 3 / 10.


How financially healthy is HIPPO HOLDINGS INC?

The financial health rating of HIPPO HOLDINGS INC (HIPO) is 5 / 10.